1. Home
  2. MGRX vs TSBX Comparison

MGRX vs TSBX Comparison

Compare MGRX & TSBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGRX
  • TSBX
  • Stock Information
  • Founded
  • MGRX 2021
  • TSBX 2015
  • Country
  • MGRX United States
  • TSBX United States
  • Employees
  • MGRX N/A
  • TSBX N/A
  • Industry
  • MGRX Computer Software: Prepackaged Software
  • TSBX
  • Sector
  • MGRX Technology
  • TSBX
  • Exchange
  • MGRX Nasdaq
  • TSBX Nasdaq
  • Market Cap
  • MGRX 8.1M
  • TSBX 7.7M
  • IPO Year
  • MGRX 2023
  • TSBX 2023
  • Fundamental
  • Price
  • MGRX $1.50
  • TSBX $0.37
  • Analyst Decision
  • MGRX
  • TSBX Buy
  • Analyst Count
  • MGRX 0
  • TSBX 3
  • Target Price
  • MGRX N/A
  • TSBX $4.75
  • AVG Volume (30 Days)
  • MGRX 160.2K
  • TSBX 459.9K
  • Earning Date
  • MGRX 08-13-2025
  • TSBX 08-13-2025
  • Dividend Yield
  • MGRX N/A
  • TSBX N/A
  • EPS Growth
  • MGRX N/A
  • TSBX N/A
  • EPS
  • MGRX N/A
  • TSBX N/A
  • Revenue
  • MGRX $511,084.00
  • TSBX N/A
  • Revenue This Year
  • MGRX N/A
  • TSBX N/A
  • Revenue Next Year
  • MGRX N/A
  • TSBX N/A
  • P/E Ratio
  • MGRX N/A
  • TSBX N/A
  • Revenue Growth
  • MGRX N/A
  • TSBX N/A
  • 52 Week Low
  • MGRX $1.32
  • TSBX $0.29
  • 52 Week High
  • MGRX $7.66
  • TSBX $2.69
  • Technical
  • Relative Strength Index (RSI)
  • MGRX 45.69
  • TSBX 54.35
  • Support Level
  • MGRX $1.41
  • TSBX $0.33
  • Resistance Level
  • MGRX $2.04
  • TSBX $0.37
  • Average True Range (ATR)
  • MGRX 0.17
  • TSBX 0.02
  • MACD
  • MGRX -0.02
  • TSBX 0.00
  • Stochastic Oscillator
  • MGRX 33.43
  • TSBX 64.17

About MGRX Mangoceuticals Inc.

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

Share on Social Networks: